newsfilter
← Latest News
Business Wire·

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

Eyecare product revenue increased 8% driven by higher sales of Avenova®-branded products through online channels Sales and marketing expenses declined 13% reflecting efficient growth through digital marketing